Nabriva Therapeutics plc - Price History
Stock symbol NBRV is outdated, potentially delisted? Maybe it is available on other exchange?
Monthly price history for NBRV (Nabriva Therapeutics plc)
Date | Adjusted price | Real price |
---|---|---|
May 2024 | $1.42 | $1.42 |
September 2023 | $0.45 | $0.45 |
August 2023 | $0.65 | $0.65 |
July 2023 | $1.42 | $1.42 |
June 2023 | $1.51 | $1.51 |
May 2023 | $1.60 | $1.60 |
April 2023 | $1.60 | $1.60 |
March 2023 | $1.75 | $1.75 |
February 2023 | $1.79 | $1.79 |
January 2023 | $1.59 | $1.59 |
December 2022 | $1.89 | $1.89 |
November 2022 | $2.25 | $2.25 |
October 2022 | $2.54 | $2.54 |
September 2022 | $2.08 | $2.08 |
August 2022 | $4.12 | $4.12 |
July 2022 | $4.48 | $4.48 |
June 2022 | $4.55 | $4.55 |
May 2022 | $5.16 | $5.16 |
April 2022 | $7.82 | $7.82 |
March 2022 | $10.50 | $10.50 |
February 2022 | $11.35 | $11.35 |
January 2022 | $12.08 | $12.08 |
December 2021 | $14.97 | $14.97 |
November 2021 | $19.47 | $19.47 |
October 2021 | $28.75 | $28.75 |
September 2021 | $29.75 | $29.75 |
August 2021 | $26.50 | $26.50 |
July 2021 | $27.50 | $27.50 |
June 2021 | $33.75 | $33.75 |
May 2021 | $34.50 | $34.50 |
April 2021 | $44.50 | $44.50 |
March 2021 | $41.50 | $41.50 |
February 2021 | $59.75 | $59.75 |
January 2021 | $65.50 | $65.50 |
December 2020 | $60.50 | $60.50 |
November 2020 | $106.75 | $106.75 |
October 2020 | $123.88 | $123.88 |
September 2020 | $133.25 | $133.25 |
August 2020 | $154.85 | $154.85 |
July 2020 | $190 | $190 |
June 2020 | $168.65 | $168.65 |
May 2020 | $285 | $285 |
April 2020 | $137.08 | $137.08 |
March 2020 | $143.75 | $143.75 |
February 2020 | $337.50 | $337.50 |
January 2020 | $337.50 | $337.50 |
December 2019 | $330 | $330 |
November 2019 | $505 | $505 |
October 2019 | $482.50 | $482.50 |
September 2019 | $500 | $500 |
August 2019 | $505 | $505 |
July 2019 | $593.75 | $593.75 |
June 2019 | $607.50 | $607.50 |
May 2019 | $572.50 | $572.50 |
April 2019 | $747.50 | $747.50 |
March 2019 | $610 | $610 |
February 2019 | $495 | $495 |
January 2019 | $475 | $475 |
December 2018 | $365 | $365 |
November 2018 | $510 | $510 |
October 2018 | $495 | $495 |
September 2018 | $675 | $675 |
August 2018 | $635 | $635 |
July 2018 | $677.50 | $677.50 |
June 2018 | $870 | $870 |
May 2018 | $1,117.50 | $1,117.50 |
April 2018 | $1,200 | $1,200 |
March 2018 | $1,257.50 | $1,257.50 |
February 2018 | $1,285 | $1,285 |
January 2018 | $1,617.50 | $1,617.50 |
December 2017 | $1,495 | $1,495 |
November 2017 | $1,605 | $1,605 |
October 2017 | $1,530 | $1,530 |
September 2017 | $2,047.50 | $2,047.50 |
August 2017 | $2,287.50 | $2,287.50 |
July 2017 | $2,620 | $2,620 |
June 2017 | $2,620 | $2,620 |
May 2017 | $2,625 | $2,625 |
April 2017 | $2,722.50 | $2,722.50 |
March 2017 | $3,000 | $3,000 |
February 2017 | $2,695 | $2,695 |
January 2017 | $1,992.50 | $1,992.50 |
December 2016 | $1,490 | $1,490 |
November 2016 | $1,015 | $1,015 |
October 2016 | $1,432.50 | $1,432.50 |
September 2016 | $1,762.50 | $1,762.50 |
August 2016 | $1,995 | $1,995 |
July 2016 | $2,107.50 | $2,107.50 |
June 2016 | $1,875 | $1,875 |
May 2016 | $1,812.50 | $1,812.50 |
April 2016 | $2,125 | $2,125 |
March 2016 | $2,240 | $2,240 |
February 2016 | $2,252.50 | $2,252.50 |
January 2016 | $2,117.50 | $2,117.50 |
December 2015 | $2,405 | $2,405 |
November 2015 | $2,548 | $2,548 |
October 2015 | $2,487.50 | $2,487.50 |
September 2015 | $2,375 | $2,375 |
NBRV
Price: $1.42
52 week price:
Earnings Per Share: -8.76 USD
P/E Ratio: -0.62
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 23200
Ebitda: -20.2 millionMarket Capitalization: 6.0 million